Patents by Inventor Stuart P. Green

Stuart P. Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SECURE VEHICLE TO VEHICLE PTC COMMUNICATION
    Publication number: 20240109564
    Abstract: A method is provided that can include activating at least two wireless communication channels in parallel, between a first wireless transceiver and a second wireless transceiver. Each of the at least two wireless communication channels can operate at a different radio carrier frequency, and the first wireless transceiver may be part of a first vehicle. The method can also include transmitting, by the first wireless transceiver, common information in parallel on the at least two wireless communication channels to the second wireless transceiver and deactivating the at least two wireless communication channels.
    Type: Application
    Filed: December 12, 2023
    Publication date: April 4, 2024
    Inventors: Padam Dhoj Swar, Carl L. Haas, Danial Rice, Rebecca W. Dreasher, Adam Hausmann, Matthew Steven Vrba, Edward J. Kuchar, James Lucas, Andrew Ryan Staats, Jerrid D. Chapman, Jeffrey D. Kernwein, Janmejay Tripathy, Stephen Craven, Tania Lindsley, Derek K. Woo, Ann K. Grimm, Scott Sollars, Phillip A. Burgart, James Allen Oswald, Shannon K. Struttmann, Stuart J. Barr, Keith Smith, Francois P. Pretorius, Craig K. Green, Kendrick Gawne, Irwin Morris, Joseph W. Gorman, Srivallidevi Muthusami, Mahesh Babu Natarajan, Jeremiah Dirnberger, Adam Franco
  • Crystalline forms of zuclomiphene citrate
    Patent number: 11661396
    Abstract: The present invention provides novel crystalline forms of zuclomiphene citrate. Specific crystalline forms provided by the present invention include zuclomiphene citrate Forms APO-I, APO-II, APO-III, and APO-IV. Also provided are pharmaceutical compositions including the zuclomiphene citrate crystalline forms, processes for the preparation thereof and the use of these forms in the treatment of a disorder selected from the group including osteoporosis, bone fractures, loss of bone mineral density (BMD) and hot flashes in a subject suffering therefrom.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: May 30, 2023
    Assignee: Apotex Inc.
    Inventors: Fabio E. S. Souza, Mohammed Abdul Raheem, Yajun Zhao, Siva Ramarao Kakani, Minh T. N. Nguyen, Alexander J. Stirk, Allan W. Rey, Stuart P. Green
  • Zuclomiphene salts and crystalline forms thereof
    Patent number: 11440871
    Abstract: The present invention provides zuclomiphene salts, zuclomiphene binaphthyl hydrogen phosphate salt (1-A)·(BPA) and zuclomiphene oxalate salt (1-A)·(OXL), crystalline forms thereof and processes for the preparation thereof.
    Type: Grant
    Filed: November 11, 2020
    Date of Patent: September 13, 2022
    Assignee: Apotex Inc.
    Inventors: Mohammed Abdul Raheem, Siva Ramarao Kakani, Minh T. N. Nguyen, Yajun Zhao, Stuart P. Green, Fabio E. S. Souza, Alexander J. Stirk, Fatemeh Mohammadpourmir
  • Crystalline form of Valbenazine dibesylate
    Patent number: 11220500
    Abstract: The present invention provides a novel crystalline form of Valbenazine dibesylate, Valbenazine dibesylate Form APO-I, compositions and processes for the preparation thereof, and the use of this crystalline form in the treatment of hyperkinetic disorders, including tardive dyskinesia.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: January 11, 2022
    Assignee: Apotex Inc.
    Inventors: Mohammed Abdul Raheem, Yajun Zhao, Minh T. N. Nguyen, Mohamed Ibrahim Zaki, Jenny L. Gerster, Stuart P. Green, Allan W. Rey
  • Crystalline Forms of Zuclomiphene Citrate
    Publication number: 20210221767
    Abstract: The present invention provides novel crystalline forms of zuclomiphene citrate. Specific crystalline forms provided by the present invention include zuclomiphene citrate Forms APO-I, APO-II, APO-III, and APO-IV. Also provided are pharmaceutical compositions including the zuclomiphene citrate crystalline forms, processes for the preparation thereof and the use of these forms in the treatment of a disorder selected from the group including osteoporosis, bone fractures, loss of bone mineral density (BMD) and hot flashes in a subject suffering therefrom.
    Type: Application
    Filed: January 21, 2021
    Publication date: July 22, 2021
    Inventors: Fabio E. S. Souza, Mohammed Abdul Raheem, Yajun Zhao, Siva Ramarao Kakani, Minh T. N. Nguyen, Alexander J. Stirk, Allan W. Rey, Stuart P. Green
  • Zuclomiphene Salts and Crystalline Forms Thereof
    Publication number: 20210147338
    Abstract: The present invention provides zuclomiphene salts, zuclomiphene binaphthyl hydrogen phosphate salt (1-A)?(BPA) and zuclomiphene oxalate salt (1-A)?(OXL), crystalline forms thereof and processes for the preparation thereof.
    Type: Application
    Filed: November 11, 2020
    Publication date: May 20, 2021
    Inventors: Mohammed Abdul Raheem, Siva Ramarao Kakani, Minh T. N. Nguyen, Yajun Zhao, Stuart P. Green, Fabio E.S. Souza, Alexander J. Stirk, Fatemeh Mohammadpourmir
  • Processes for the preparation of Tezacaftor and intermediates thereof
    Patent number: 10875846
    Abstract: The present invention provides processes for the preparation of Tezacaftor, as well as intermediates useful in the preparation thereof. In particular, processes are provided for the preparation of a compound of Formula (3), and its conversion to Tezacaftor (1).
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: December 29, 2020
    Assignee: Apotex Inc.
    Inventors: Michael R. Emmett, Prabhudas Bodhuri, Yajun Zhao, Eduardo Gustavo Cammisa, Stuart P. Green
  • Processes for the Preparation of Tezacaftor and Intermediates Thereof
    Publication number: 20200223832
    Abstract: The present invention provides processes for the preparation of Tezacaftor, as well as intermediates useful in the preparation thereof. In particular, processes are provided for the preparation of a compound of Formula (3), and its conversion to Tezacaftor (1).
    Type: Application
    Filed: January 13, 2020
    Publication date: July 16, 2020
    Inventors: Michael R. Emmett, Prabhudas Bodhuri, Yajun Zhao, Eduardo Gustavo Cammisa, Stuart P. Green
  • Crystalline Form of Valbenazine Dibesylate
    Publication number: 20200207761
    Abstract: The present invention provides a novel crystalline form of Valbenazine dibesylate, Valbenazine dibesylate Form APO-I, compositions and processes for the preparation thereof, and the use of this crystalline form in the treatment of hyperkinetic disorders, including tardive dyskinesia.
    Type: Application
    Filed: December 18, 2019
    Publication date: July 2, 2020
    Inventors: Mohammed Abdul Raheem, Yajun Zhao, Minh T. N. Nguyen, Mohamed Ibrahim Zaki, Jenny L. Gerster, Stuart P. Green, Allan W. Rey
  • Processes for the preparation of edoxaban and intermediates thereof
    Patent number: 10301322
    Abstract: The present invention provides processes for the preparation of Edoxaban (1) and salts thereof, as well as intermediates thereof. In particular, intermediate compounds and/or salts of the Formulae (3), (4), (6-A), (7-A), (8-A), (9-A) and (10-AS) are provided.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: May 28, 2019
    Assignee: Apotex Inc.
    Inventors: Prabhudas Bodhuri, Avedis Karadeolian, Eduardo Gustavo Cammisa, Stuart P. Green, Melanie R. A. Green, Alfredo Paul Ceccarelli
  • Processes for the Preparation of Edoxaban and Intermediates Thereof
    Publication number: 20180179226
    Abstract: The present invention provides processes for the preparation of Edoxaban (1) and salts thereof, as well as intermediates thereof. In particular, intermediate compounds and/or salts of the Formulae (3), (4), (6-A), (7-A), (8-A), (9-A) and (10-AS) are provided.
    Type: Application
    Filed: December 21, 2017
    Publication date: June 28, 2018
    Inventors: Prabhudas Bodhuri, Avedis Karadeolian, Eduardo Gustavo Cammisa, Stuart P. Green, Melanie R. A. Green, Alfredo Paul Ceccarelli
  • Solid Forms of Mirabegron
    Publication number: 20170291882
    Abstract: Solid forms of Mirabegron, including forms APO-I, APO-II, and various salt forms, and processes for the preparation thereof, are provided.
    Type: Application
    Filed: October 1, 2015
    Publication date: October 12, 2017
    Inventors: Allan W. Rey, Annyt Bhattacharyya, Jenny L. Gerster, Sammy Chris Duncan, Mohammed Abdul Raheem, Fan Wang, Stuart P. Green
  • Process for the Preparation of Olaparib and Intermediates Thereof
    Publication number: 20170233351
    Abstract: The present invention provides processes for the preparation of intermediate compounds of formulas (4) and (5) useful in the preparation of Olaparib.
    Type: Application
    Filed: February 10, 2017
    Publication date: August 17, 2017
    Inventors: Svetoslav S. Bratovanov, Stuart P. Green
  • Solid forms of tofacitinib salts
    Patent number: 9260438
    Abstract: Solid and crystalline forms of tofacitinib hydrochloride and tofacitinib hydrobromide, processes for the preparation thereof and processes for the use thereof in preparing tofacitinib citrate are provided.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: February 16, 2016
    Assignee: Apotex Inc.
    Inventors: Prabhudas Bodhuri, Stuart P. Green, Fan Wang, Cameron L. McPhail, Eduardo Gustavo Cammisa, Avedis Karadeolian
  • SOLID FORMS OF TOFACITINIB SALTS
    Publication number: 20150225406
    Abstract: Solid and crystalline forms of tofacitinib hydrochloride and tofacitinib hydrobromide, processes for the preparation thereof and processes for the use thereof in preparing tofacitinib citrate are provided.
    Type: Application
    Filed: February 6, 2015
    Publication date: August 13, 2015
    Inventors: Prabhudas Bodhuri, Stuart P. Green, Fan Wang, Cameron L. McPhail, Eduardo Gustavo Cammisa, Avedis Karadeolian